114 related articles for article (PubMed ID: 34597849)
1. Transglutaminase 3 expression in hepatocellular carcinoma patients: Correlation with tumor features and survival profile.
Wu D; Zhang R; Zhan L
Clin Res Hepatol Gastroenterol; 2022 Mar; 46(3):101812. PubMed ID: 34597849
[TBL] [Abstract][Full Text] [Related]
2. Higher tumor protein kinase D1 correlates with increased tumor size, BCLC stage, CA199 level, AFP level and worse overall survival in hepatocellular carcinoma patients.
Ge J; Zhang X; Zhang B; Zhu L; Zhao M; Gao W; Chen D
Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101573. PubMed ID: 33281070
[TBL] [Abstract][Full Text] [Related]
3. CCT6A expression in hepatocellular carcinoma and its correlation with clinical characteristics, liver function indexes, tumor markers and prognosis.
Cai Y; Wu D; Zhan L
Clin Res Hepatol Gastroenterol; 2022 Mar; 46(3):101796. PubMed ID: 34500119
[TBL] [Abstract][Full Text] [Related]
4. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
5. TGM3 promotes epithelial-mesenchymal transition and hepatocellular carcinogenesis and predicts poor prognosis for patients after curative resection.
Hu JW; Yang ZF; Li J; Hu B; Luo CB; Zhu K; Dai Z; Cai JB; Zhan H; Hu ZQ; Hu J; Cao Y; Qiu SJ; Zhou J; Fan J; Huang XW
Dig Liver Dis; 2020 Jun; 52(6):668-676. PubMed ID: 31822388
[TBL] [Abstract][Full Text] [Related]
6. Value of α-fetoprotein in association with clinicopathological features of hepatocellular carcinoma.
Liu C; Xiao GQ; Yan LN; Li B; Jiang L; Wen TF; Wang WT; Xu MQ; Yang JY
World J Gastroenterol; 2013 Mar; 19(11):1811-9. PubMed ID: 23555170
[TBL] [Abstract][Full Text] [Related]
7. A-kinase interacting protein 1 (AKIP1) associates with advanced overall disease condition, tumor properties, and unfavorable prognosis in hepatocellular carcinoma patients.
Fang T; Lu Q
J Clin Lab Anal; 2020 Jun; 34(6):e23213. PubMed ID: 32133702
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma.
Ilikhan SU; Bilici M; Sahin H; Akca AS; Can M; Oz II; Guven B; Buyukuysal MC; Ustundag Y
World J Gastroenterol; 2015 Jun; 21(22):6999-7007. PubMed ID: 26078578
[TBL] [Abstract][Full Text] [Related]
9. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal circulating tumor cells and Ki67: their mutual correlation and prognostic implications in hepatocellular carcinoma.
Yang X; Ni H; Lu Z; Zhang J; Zhang Q; Ning S; Qi L; Xiang B
BMC Cancer; 2023 Jan; 23(1):10. PubMed ID: 36600214
[TBL] [Abstract][Full Text] [Related]
11. Dysregulated circ_0004913, circ_0008160, circ_0000517, and their potential as biomarkers for disease monitoring and prognosis in hepatocellular carcinoma.
Li X; Yang J; Yang X; Cao T
J Clin Lab Anal; 2021 Jun; 35(6):e23785. PubMed ID: 34018640
[TBL] [Abstract][Full Text] [Related]
12. Circular RNA 0016788 displays as a biomarker for tumor progression and poor prognosis in surgical hepatocellular carcinoma patients.
Cheng F; Wang L; Zhang J
J Clin Lab Anal; 2020 Jul; 34(7):e23300. PubMed ID: 32319701
[TBL] [Abstract][Full Text] [Related]
13. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC
Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374
[TBL] [Abstract][Full Text] [Related]
14. Importance of SALL4 in the development and prognosis of hepatocellular carcinoma.
Yin F; Han X; Yao SK; Wang XL; Yang HC
World J Gastroenterol; 2016 Mar; 22(9):2837-43. PubMed ID: 26973422
[TBL] [Abstract][Full Text] [Related]
15. Expression of β-catenin protein in hepatocellular carcinoma and its relationship with alpha-fetoprotein.
Ren YJ; Huang T; Yu HL; Zhang L; He QJ; Xiong ZF; Peng H
J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):846-851. PubMed ID: 27924522
[TBL] [Abstract][Full Text] [Related]
16. Long Non-Coding RNA MAFG-AS1 as a Potential Biomarker for Hepatocellular Carcinoma: Linkage with Tumor Features, Markers, Liver Functions, and Survival Profile.
Tian Y; Wang J; Tian G; Li B; Chen M; Sun X
Front Surg; 2022; 9():848831. PubMed ID: 36034393
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of hepatocellular carcinoma patients with normal serum alpha-fetoprotein level: A study of 112 consecutive cases.
Li L; Chen J; Xu W; Ding X; Wang X; Liang J
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e336-e340. PubMed ID: 29071776
[TBL] [Abstract][Full Text] [Related]
18. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
[TBL] [Abstract][Full Text] [Related]
19. The clinical value of kinesin superfamily protein 2A in hepatocellular carcinoma.
Liu W; Xu C; Meng Q; Kang P
Clin Res Hepatol Gastroenterol; 2021 Jul; 45(4):101527. PubMed ID: 33713978
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
[No Abstract] [Full Text] [Related]
[Next] [New Search]